Evidence map›Paper›PMID 31355305›Full record

ArticleNeurology(R) neuroimmunology & neuroinflammation2019

IgA autoantibodies against native myelin basic protein in a patient with MS.

Heike Schumacher, Nina K Wenke, Jakob Kreye, Markus Höltje, Katrin Marcus, Caroline May, Harald Prüss

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology(R) neuroimmunology & neuroinflammation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Heike SchumacherGerman Center for Neurodegenerative Diseases (DZNE) Berlin (H.S., N.K.W., J.K., H.P.); Institute of Integrative Neuroanatomy (M.H.), Charité-Universitätsmedizin Berlin; Medizinisches Proteom-Center (K.M., C.M.), Ruhr-University Bochum; Department of Neurology and Experimental Neurology (H.P.), Charité-Universitätsmedizin Berlin; and Center for Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes (H.P.), Berlin, Germany.
Nina K WenkeGerman Center for Neurodegenerative Diseases (DZNE) Berlin (H.S., N.K.W., J.K., H.P.); Institute of Integrative Neuroanatomy (M.H.), Charité-Universitätsmedizin Berlin; Medizinisches Proteom-Center (K.M., C.M.), Ruhr-University Bochum; Department of Neurology and Experimental Neurology (H.P.), Charité-Universitätsmedizin Berlin; and Center for Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes (H.P.), Berlin, Germany.
Jakob KreyeGerman Center for Neurodegenerative Diseases (DZNE) Berlin (H.S., N.K.W., J.K., H.P.); Institute of Integrative Neuroanatomy (M.H.), Charité-Universitätsmedizin Berlin; Medizinisches Proteom-Center (K.M., C.M.), Ruhr-University Bochum; Department of Neurology and Experimental Neurology (H.P.), Charité-Universitätsmedizin Berlin; and Center for Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes (H.P.), Berlin, Germany.
Markus HöltjeGerman Center for Neurodegenerative Diseases (DZNE) Berlin (H.S., N.K.W., J.K., H.P.); Institute of Integrative Neuroanatomy (M.H.), Charité-Universitätsmedizin Berlin; Medizinisches Proteom-Center (K.M., C.M.), Ruhr-University Bochum; Department of Neurology and Experimental Neurology (H.P.), Charité-Universitätsmedizin Berlin; and Center for Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes (H.P.), Berlin, Germany.
Katrin MarcusGerman Center for Neurodegenerative Diseases (DZNE) Berlin (H.S., N.K.W., J.K., H.P.); Institute of Integrative Neuroanatomy (M.H.), Charité-Universitätsmedizin Berlin; Medizinisches Proteom-Center (K.M., C.M.), Ruhr-University Bochum; Department of Neurology and Experimental Neurology (H.P.), Charité-Universitätsmedizin Berlin; and Center for Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes (H.P.), Berlin, Germany.
Caroline MayGerman Center for Neurodegenerative Diseases (DZNE) Berlin (H.S., N.K.W., J.K., H.P.); Institute of Integrative Neuroanatomy (M.H.), Charité-Universitätsmedizin Berlin; Medizinisches Proteom-Center (K.M., C.M.), Ruhr-University Bochum; Department of Neurology and Experimental Neurology (H.P.), Charité-Universitätsmedizin Berlin; and Center for Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes (H.P.), Berlin, Germany.
Harald PrüssGerman Center for Neurodegenerative Diseases (DZNE) Berlin (H.S., N.K.W., J.K., H.P.); Institute of Integrative Neuroanatomy (M.H.), Charité-Universitätsmedizin Berlin; Medizinisches Proteom-Center (K.M., C.M.), Ruhr-University Bochum; Department of Neurology and Experimental Neurology (H.P.), Charité-Universitätsmedizin Berlin; and Center for Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes (H.P.), Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAutoantibodiesCognitive DysfunctionFemaleHumansImmunoglobulin AImmunotherapyMiceMice, KnockoutMiddle AgedMultiple SclerosisMyelin Basic ProteinMyelin-Oligodendrocyte GlycoproteinRatsAutoantibodiesImmunoglobulin AMyelin Basic ProteinMyelin-Oligodendrocyte Glycoprotein

Identifiers

PMID31355305
PMCPMC6624097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.